Subtopic Deep Dive

Anticoccidial Drug Resistance in Eimeria
Research Guide

What is Anticoccidial Drug Resistance in Eimeria?

Anticoccidial drug resistance in Eimeria refers to the reduced efficacy of ionophores and synthetic anticoccidials against field isolates of Eimeria parasites in poultry due to genetic adaptations.

Resistance has developed to all major anticoccidial classes used in poultry production. Chapman (1997) details biochemical and genetic mechanisms in Eimeria parasites (315 citations). Peek and Landman (2011) report worldwide emergence from long-term drug use (384 citations).

Curated Papers

Key Challenges

Why It Matters

Resistance threatens poultry industry profitability, with coccidiosis costing billions annually as quantified by Blake et al. (2020, 597 citations). Chapman (1997) emphasizes that understanding resistance is crucial for sustaining chemotherapy efficacy. Blake and Tomley (2013, 452 citations) highlight the need for resistance management to secure global chicken production. Noack et al. (2019, 266 citations) review drugs at risk, underscoring economic impacts on livestock.

Key Research Challenges

Genetic Basis Identification

Mapping specific mutations conferring resistance in Eimeria genomes remains incomplete. Reid et al. (2014) provide genomic data on Eimeria species but lack targeted resistance loci (250 citations). Chapman (1997) notes genetic markers vary by drug class and isolate.

Fitness Cost Measurement

Quantifying trade-offs between resistance and parasite fitness in field conditions is challenging. Allen and Fetterer (2002) discuss control strategies but highlight variable fitness impacts (494 citations). Danzeisen et al. (2011) link anticoccidials to microbiome changes affecting fitness (357 citations).

Resistance Detection Assays

Developing reliable, rapid assays for field surveillance of resistance is limited. Peek and Landman (2011) stress the need for monitoring amid widespread resistance (384 citations). Williams (2002) evaluates vaccines as alternatives but notes assay gaps (340 citations).

Essential Papers

Re-calculating the cost of coccidiosis in chickens

Damer P. Blake, Jolene Knox, Ben Dehaeck et al. · 2020 · Veterinary Research · 597 citations

Recent Advances in Biology and Immunobiology of<i>Eimeria</i>Species and in Diagnosis and Control of Infection with These Coccidian Parasites of Poultry

P. C. Allen, R.H. Fetterer · 2002 · Clinical Microbiology Reviews · 494 citations

SUMMARY Avian coccidiosis, an intestinal disease caused by protozoan parasites of the genus Eimeria, occurs worldwide. It is considered to be one of the most economically important diseases of dome...

Securing poultry production from the ever-present Eimeria challenge

Damer P. Blake, Fiona M. Tomley · 2013 · Trends in Parasitology · 452 citations

Coccidiosis in poultry: anticoccidial products, vaccines and other prevention strategies

H. W. Peek, W. J. M. Landman · 2011 · Veterinary Quarterly · 384 citations

Coccidiosis in chickens is a parasitic disease with great economic significance, which has been controlled successfully for decades using mainly anticoccidial products. However, large-scale and lon...

Modulations of the Chicken Cecal Microbiome and Metagenome in Response to Anticoccidial and Growth Promoter Treatment

Jessica L. Danzeisen, Hyeun Bum Kim, Richard E. Isaacson et al. · 2011 · PLoS ONE · 357 citations

With increasing pressures to reduce or eliminate the use of antimicrobials for growth promotion purposes in production animals, there is a growing need to better understand the effects elicited by ...

Anticoccidial vaccines for broiler chickens: Pathways to success

R. B. Williams · 2002 · Avian Pathology · 340 citations

The use of live vaccines, either attenuated or non-attenuated, for the control of coccidiosis due to Eimeria infections in broiler breeder or layer chickens is well established. Use in broilers, ho...

Biochemical, genetic and applied aspects of drug resistance in<i>Eimeria</i>parasites of the fowl

H. D. Chapman · 1997 · Avian Pathology · 315 citations

Anticoccidial drugs are widely used for the control of coccidiosis in the fowl which has inevitably led to the development of drug resistance. Resistance has developed to all of the compounds that ...

Reading Guide

Foundational Papers

Start with Chapman (1997, 315 citations) for core biochemical and genetic resistance mechanisms; Allen and Fetterer (2002, 494 citations) for biology and control context; Peek and Landman (2011, 384 citations) for emergence patterns.

Recent Advances

Blake et al. (2020, 597 citations) for updated economic impacts; Noack et al. (2019, 266 citations) for current anticoccidial drugs; Reid et al. (2014, 250 citations) for genomic advances.

Core Methods

Genetic sequencing (Reid et al. 2014), in vivo selection assays (Chapman 1997), microbiome analysis under treatment (Danzeisen et al. 2011), and economic modeling (Blake et al. 2020).

How PapersFlow Helps You Research Anticoccidial Drug Resistance in Eimeria

Discover & Search

Research Agent uses searchPapers and citationGraph to map resistance literature from Chapman (1997) to Noack et al. (2019), revealing 315-cited biochemical mechanisms. exaSearch uncovers field isolate studies; findSimilarPapers extends from Blake et al. (2020, 597 citations) to rotation strategies.

Analyze & Verify

Analysis Agent applies readPaperContent on Chapman (1997) for genetic marker extraction, then verifyResponse (CoVe) checks claims against Allen and Fetterer (2002). runPythonAnalysis with pandas processes resistance prevalence data from Peek and Landman (2011); GRADE grading scores evidence on fitness costs.

Synthesize & Write

Synthesis Agent detects gaps in rotation strategies post-Chapman (1997), flags contradictions between Blake and Tomley (2013) and Noack et al. (2019). Writing Agent uses latexEditText, latexSyncCitations for resistance review papers, latexCompile for publication-ready drafts, exportMermaid for mechanism diagrams.

Use Cases

"Analyze fitness costs of monensin resistance in Eimeria field isolates using stats"

Research Agent → searchPapers('Eimeria monensin fitness cost') → Analysis Agent → readPaperContent(Chapman 1997) + runPythonAnalysis(pandas on prevalence data) → statistical summary with p-values and plots.

"Draft LaTeX review on ionophore resistance mechanisms citing Blake 2020"

Synthesis Agent → gap detection on resistance dynamics → Writing Agent → latexEditText(structured review) → latexSyncCitations(Blake et al. 2020, Chapman 1997) → latexCompile → PDF with diagrams.

"Find code for Eimeria genomic resistance marker analysis"

Research Agent → paperExtractUrls(Reid et al. 2014 genome paper) → Code Discovery → paperFindGithubRepo → githubRepoInspect → runnable Python scripts for SNP detection in Eimeria sequences.

Automated Workflows

Deep Research workflow conducts systematic review of 50+ Eimeria resistance papers: searchPapers → citationGraph(Chapman 1997 hub) → structured report with GRADE scores. DeepScan applies 7-step analysis to field isolates: readPaperContent(Peek 2011) → CoVe verification → Python fitness modeling. Theorizer generates hypotheses on multi-drug resistance from Blake (2020) and Noack (2019) trends.

Try Doxa for Anticoccidial Drug Resistance in Eimeria Research

Frequently Asked Questions

What defines anticoccidial drug resistance in Eimeria?

Reduced susceptibility of Eimeria parasites to ionophores or synthetics due to genetic changes in field isolates. Chapman (1997) documents resistance to all introduced compounds. Peek and Landman (2011) link it to long-term prophylactic use.

What are key methods for studying Eimeria resistance?

Genetic marker analysis, oocyst production assays, and fitness cost experiments. Chapman (1997) reviews biochemical and genetic approaches. Reid et al. (2014) apply genomics to causative agents.

What are major papers on this topic?

Chapman (1997, 315 citations) on mechanisms; Peek and Landman (2011, 384 citations) on emergence; Blake et al. (2020, 597 citations) on economic costs; Noack et al. (2019, 266 citations) on livestock drugs.

What open problems exist?

Rapid field detection assays, precise genomic loci for all drugs, and effective rotation models. Allen and Fetterer (2002) note control gaps; Blake and Tomley (2013) call for sustained management strategies.